Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Institute of Oncology Ljubljana
Liubliana, EsloveniaPublikationen in Zusammenarbeit mit Forschern von Institute of Oncology Ljubljana (6)
2023
-
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
The Lancet. Oncology, Vol. 24, Núm. 1, pp. 91-106
2022
-
Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis
Gynecologic Oncology, Vol. 164, Núm. 3, pp. 498-504
-
Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
Cancer Discovery, Vol. 12, Núm. 5, pp. 1248-1265
2021
-
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
The Lancet Oncology, Vol. 22, Núm. 4, pp. 476-488
-
The ESSO core curriculum committee update on surgical oncology
European Journal of Surgical Oncology, Vol. 47, Núm. 11, pp. e1-e30
2016
-
70-Gene signature as an aid to treatment decisions in early-stage breast cancer
New England Journal of Medicine, Vol. 375, Núm. 8, pp. 717-729